Bronchoscopic Assessment of the Evolution of Endobronchial Tuberculosis

Chung, Hee Soon; Lee, Jae Ho

doi:10.1378/chest.117.2.385

Cited by 208 publications

(269 citation statements)

References 27 publications

Supporting

Mentioning

231

Contrasting

Unclassified

Order By: Relevance

“…Aktif pulmoner TB'li hastaların %10-40'ında görülür (18). Literatürde EBTB'li hastaların demografik, klinik, radyolojik ve bronkoskopik özelliklerini irdeleyen çalışmalar bulunmaktadır (19)(20)(21)(22)(23). Bu çalışma-ların birinde 121 EBTB'li hastanın özellikleri retrospektif araştırılmıştır.…”

Section: Discussionunclassified

“…Aynı çalışmada hastaların bronkoskopi incelemelerinde granüloma, basit bronşit, granülomatöz bronşit ve ülseratif bronşit gibi bulgular saptandığı belirtilmiştir (20). Bronkoskopik incelemelerde EBTB lezyonları; aktif kazeifikasyon, tömöral, fibrostenotik, ödematöz-hiperemik, granüler ve nonspesifik bronşitik özelliklerde görülebilmektedir (21). Bizim olgumuzda 53 yaşında kadın hastaydı.…”

Section: Discussionunclassified

See 1 more Smart Citation

A case of endobronchial tuberculosis developed under anti-TNF-alpha treatment

Berk¹,

Odabaşı²,

Doǧan³

et al. 2014

Respir Case Rep

View full text Add to dashboard Cite

Section: Discussionunclassified

A case of endobronchial tuberculosis developed under anti-TNF-alpha treatment

Berk¹,

Odabaşı²,

Doǧan³

et al. 2014

Respir Case Rep

View full text Add to dashboard Cite

“…Akciğer tüberkülozunda endobronşiyal tüberküloz gelişme insidansının %5,8 oranında olduğu bildirilmiştir. Ancak her tüberkülozlu hastaya bronkoskopik muayene yapılmadığı için gerçek insidansın bu orandan yüksek olduğu düşünülmektedir (5). Endobronşiyal lezyonların tanı ve takibinde esas olan bronkoskopik incelemedir.…”

Section: şEkil 5: 2 Aylık Tüberküloz Tedavi Sonrası Posterio-anteriorunclassified

The Importance of Bronchoscopy in the Diagnosis of Endobronchial Tuberculosis

Yılmaz¹,

Havan²

2014

Respir Case Rep

View full text Add to dashboard Cite

“…25 Diagnosis and response to therapy may be assessed through bronchoscopy. 26 ExTraPulmonary TB Extrapulmonary TB accounts for roughly 15% of TB cases among immunocompetent hosts 27 and for 50% to For personal use. Mass reproduce only with permission from Mayo Clinic Proceedings a .…”

Section: Pulmonary Tbmentioning

confidence: 99%

Current Concepts in the Management of Tuberculosis

Sia

Wieland

2011

Mayo Clinic Proceedings

162

108

View full text Add to dashboard Cite

E ffective medical therapy for tuberculosis (TB) has existed for more than half a century, yet TB remains among the most pressing public health issues of our day. Tuberculosis is, in part, a disease of poverty. 1 The fact that it remains the eighth leading cause of death in the world speaks to the challenges facing practitioners and public health officials as they try to control a disease that is so entwined in the cultural and economic fabric of society. Challenges to effective solutions include lack of access to diagnosis and treatment, the frequent coexistence of epidemics of TB and human immunodeficiency virus (HIV), and the Tuberculosis (TB) poses a serious threat to public health throughout the world but disproportionately afflicts low-income nations. Persons in close contact with a patient with active pulmonary TB and those from endemic regions of the world are at highest risk of primary infection, whereas patients with compromised immune systems are at highest risk of reactivation of latent TB infection (LTBI). Tuberculosis can affect any organ system. Clinical manifestations vary accordingly but often include fever, night sweats, and weight loss. Positive results on either a tuberculin skin test or an interferon-γ release assay in the absence of active TB establish a diagnosis of LTBI. A combination of epidemiological, clinical, radiographic, microbiological, and histopathologic features is used to establish the diagnosis of active TB. Patients with suspected active pulmonary TB should submit 3 sputum specimens for acidfast bacilli smears and culture, with nucleic acid amplification testing performed on at least 1 specimen. For patients with LTBI, treatment with isoniazid for 9 months is preferred. Patients with active TB should be treated with multiple agents to achieve bacterial clearance, to reduce the risk of transmission, and to prevent the emergence of drug resistance. Directly observed therapy is recommended for the treatment of active TB. Health care professionals should collaborate, when possible, with local and state public health departments to care for patients with TB. Patients with drug-resistant TB or coinfection with human immunodeficiency virus should be treated in collaboration with TB specialists. Public health measures to prevent the spread of TB include appropriate respiratory isolation of patients with active pulmonary TB, contact investigation, and reduction of the LTBI burden. Proc. 2011;86(4):348-361 AFB = acid-fast bacilli; BCG = bacille Calmette-Guérin; CFP-10 = culture filtrate protein 10; DOT = directly observed therapy; EMB = ethambutol; ESAT-6 = early-secreted antigenic target 6; HIV = human immuno deficiency virus; IFN-γ = interferon-γ; IGRA = IFN-γ release assay; INH = isoniazid; LTBI = latent TBI; MDR-TB = multidrug-resistant TB; NAA = nucleic acid amplification; PZA = pyrazinamide; RIF = rifampin; TB = tuberculosis; TBI = TB infection; TST = tuberculin skin test; XDR-TB = extensively drug-resistant TB Mayo Clin

show abstract

Bronchoscopic Assessment of the Evolution of Endobronchial Tuberculosis

Cited by 208 publications

References 27 publications

A case of endobronchial tuberculosis developed under anti-TNF-alpha treatment

A case of endobronchial tuberculosis developed under anti-TNF-alpha treatment

The Importance of Bronchoscopy in the Diagnosis of Endobronchial Tuberculosis

Current Concepts in the Management of Tuberculosis

Contact Info

Product

Resources

About